Annual SG&A
$15.74 M
+$5.00 M+46.53%
31 December 2022
Summary:
Rain Therapeutics annual selling, general & administrative expenses is currently $15.74 million, with the most recent change of +$5.00 million (+46.53%) on 31 December 2022. During the last 3 years, it has risen by +$12.14 million (+338.21%).RAIN Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$4.11 M
-$1.30 M-24.03%
30 September 2023
Summary:
Rain Therapeutics quarterly selling, general & administrative expenses is currently $4.11 million, with the most recent change of -$1.30 million (-24.03%) on 30 September 2023.RAIN Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$775.37 M
-$72.26 M-10.28%
30 September 2023
Summary:
Rain Therapeutics TTM selling, general & administrative expenses is currently -$775.37 million, with the most recent change of -$72.26 million (-10.28%) on 30 September 2023.RAIN TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RAIN Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +338.2% | +30.4% | -9101.2% |
| 5 y5 years | - | - | - |
RAIN Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | at high | -24.0% | -4165.5% |
Rain Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $4.11 M(-24.0%) | $19.07 M(+1.1%) |
| June 2023 | - | $5.41 M(+6.9%) | $18.86 M(+11.6%) |
| Mar 2023 | - | $5.07 M(+13.1%) | $16.91 M(+7.4%) |
| Dec 2022 | $15.74 M(+46.5%) | $4.48 M(+14.8%) | $15.74 M(+7.3%) |
| Sept 2022 | - | $3.90 M(+12.7%) | $14.66 M(+5.4%) |
| June 2022 | - | $3.46 M(-11.1%) | $13.91 M(+5.8%) |
| Mar 2022 | - | $3.90 M(+14.4%) | $13.15 M(+22.5%) |
| Dec 2021 | $10.74 M | $3.40 M(+8.0%) | $10.74 M(+24.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $3.15 M(+16.8%) | $8.61 M(+42.4%) |
| June 2021 | - | $2.70 M(+82.4%) | $6.05 M(+35.4%) |
| Mar 2021 | - | $1.48 M(+15.6%) | $4.47 M(+22.2%) |
| Dec 2020 | $3.59 M(+1.5%) | $1.28 M(+116.6%) | $3.66 M(+53.8%) |
| Sept 2020 | - | $591.00 K(-47.2%) | $2.38 M(+33.1%) |
| June 2020 | - | $1.12 M(+67.5%) | $1.79 M(+167.5%) |
| Mar 2020 | - | $668.00 K | $668.00 K |
| Dec 2019 | $3.54 M | - | - |
FAQ
- What is Rain Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Rain Therapeutics?
- What is Rain Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Rain Therapeutics?
- What is Rain Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Rain Therapeutics?
What is Rain Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of RAIN is $15.74 M
What is the all time high annual SG&A for Rain Therapeutics?
Rain Therapeutics all-time high annual selling, general & administrative expenses is $15.74 M
What is Rain Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of RAIN is $4.11 M
What is the all time high quarterly SG&A for Rain Therapeutics?
Rain Therapeutics all-time high quarterly selling, general & administrative expenses is $5.41 M
What is Rain Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of RAIN is -$775.37 M
What is the all time high TTM SG&A for Rain Therapeutics?
Rain Therapeutics all-time high TTM selling, general & administrative expenses is $19.07 M